These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 5546927)

  • 1. Induction of hyperinsulinemia and hyperglycemia in dogs by administration of diabetogenic bovine pituitary peptide.
    Louis LH; Conn JW; Appelt MM
    Metabolism; 1971 Mar; 20(3):326-30. PubMed ID: 5546927
    [No Abstract]   [Full Text] [Related]  

  • 2. A diabetogenic polypeptide from hog and sheep adenohypophysis similar to that found in lipoatrophic diabetes.
    Louis LH; Conn JW
    Metabolism; 1968 Jun; 17(6):475-84. PubMed ID: 5651597
    [No Abstract]   [Full Text] [Related]  

  • 3. Diabetogenic activity of the anterior pituitary (a progress report).
    Tutwiler GF
    Acta Diabetol Lat; 1976; 13(5-6):177-85. PubMed ID: 800921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hyperinsulinemia and/or hyperglycemia in insulin-treated diabetic patients? Choice of relative risks].
    Tchobroutsky G
    Journ Annu Diabetol Hotel Dieu; 1990; ():211-22. PubMed ID: 2195207
    [No Abstract]   [Full Text] [Related]  

  • 5. Diabetogenic effects of streptozotocin in rhesus monkeys.
    Pitkin RM; Reynolds WA
    Diabetes; 1970 Feb; 19(2):85-90. PubMed ID: 4984216
    [No Abstract]   [Full Text] [Related]  

  • 6. S961, an insulin receptor antagonist causes hyperinsulinemia, insulin-resistance and depletion of energy stores in rats.
    Vikram A; Jena G
    Biochem Biophys Res Commun; 2010 Jul; 398(2):260-5. PubMed ID: 20599729
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin-resistant hyperglycemia produced by aminophylline.
    Penhos JC; Lazarus NR; Yamaguchi N; Gutman RA; Recant L
    Isr J Med Sci; 1972 Jun; 8(6):917-8. PubMed ID: 5051844
    [No Abstract]   [Full Text] [Related]  

  • 8. A diabetogenic polypeptide from bovine adenohypophysis similar to that excreted in lipoatrophic diabetes.
    Louis LH; Conn JW; Minick MC
    Metabolism; 1966 Apr; 15(4):309-24. PubMed ID: 4285865
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoatrophic diabetes: an improved procedure for the isolation and purification of a diabetogenic polypeptide from urine.
    Louis LH
    Metabolism; 1969 Jul; 18(7):545-55. PubMed ID: 5788258
    [No Abstract]   [Full Text] [Related]  

  • 10. Anti-insulin actions of a bovine pituitary diabetogenic peptide on glycogen synthesis.
    Miller TB; Larner J
    Proc Natl Acad Sci U S A; 1972 Oct; 69(10):2774-7. PubMed ID: 4628094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective Effect of Vanillic Acid against Hyperinsulinemia, Hyperglycemia and Hyperlipidemia via Alleviating Hepatic Insulin Resistance and Inflammation in High-Fat Diet (HFD)-Fed Rats.
    Chang WC; Wu JS; Chen CW; Kuo PL; Chien HM; Wang YT; Shen SC
    Nutrients; 2015 Dec; 7(12):9946-59. PubMed ID: 26633482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetes in patients treated with asparaginase.
    Gailani S; Nussbaum A; Onuma T; Freeman A
    Clin Pharmacol Ther; 1971; 12(3):487-90. PubMed ID: 5284834
    [No Abstract]   [Full Text] [Related]  

  • 13. Hyperglycemia and inhibition of insulin secretion during administration of diazoxide and trichlormethiazide in man.
    Seltzer HS; Allen EW
    Diabetes; 1969 Jan; 18(1):19-28. PubMed ID: 5761863
    [No Abstract]   [Full Text] [Related]  

  • 14. [Diabetogenic activity of diazoxide].
    Zahnd GR; Luyckx A
    Helv Med Acta Suppl; 1966 May; 46():163. PubMed ID: 5286273
    [No Abstract]   [Full Text] [Related]  

  • 15. Hyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle.
    Lee Y; Fluckey JD; Chakraborty S; Muthuchamy M
    FASEB J; 2017 Jul; 31(7):2744-2759. PubMed ID: 28298335
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Salidiuretics and glycoregulation].
    Kuntzmann F; Brogard JM; Dorner M; Stahl J
    Diabete; 1971; 19(3):135-40. PubMed ID: 4944918
    [No Abstract]   [Full Text] [Related]  

  • 17. [The value of radioimmunological determination of plasmatic insulin in the course of induced hyperglycemia in children].
    Turcanu L; Alexandru F; Deutsch G; Dreichlinger O; Popa I; Murgu L; Breitman V
    Pediatria (Bucur); 1974 Jan; 23(1):1-9. PubMed ID: 4842555
    [No Abstract]   [Full Text] [Related]  

  • 18. The involvement of insulin in tryptamine-induced hypoglycemia in mice.
    Sugimoto Y; Kimura I; Yamada J; Watanabe Y; Takeuchi N; Horisaka K
    Life Sci; 1991; 48(17):1679-83. PubMed ID: 2016997
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Blood insulin and diabetes. I. Method of study--normal subjects--diabetic disease].
    Duprey J; Lubetzki J
    Pathol Biol (Paris); 1971 Mar; 19(5):311-31. PubMed ID: 4929994
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin treatment and new-onset diabetes: a review of proposed mechanisms.
    Brault M; Ray J; Gomez YH; Mantzoros CS; Daskalopoulou SS
    Metabolism; 2014 Jun; 63(6):735-45. PubMed ID: 24641882
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.